La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Sansure Biotech Résultats passés
Nous sommes encore en train de traiter le dernier rapport sur les résultats de cette entreprise.
Passé contrôle des critères 1/6
Sansure Biotech's earnings have been declining at an average annual rate of -9%, while the Medical Equipment industry saw earnings growing at 5.8% annually. Revenues have been declining at an average rate of 25.2% per year. Sansure Biotech's return on equity is 4.8%, and it has net margins of 32%.
Informations clés
-9.0%
Taux de croissance des bénéfices
-9.4%
Taux de croissance du BPA
| Medical Equipment Croissance de l'industrie | 16.0% |
| Taux de croissance des recettes | -25.2% |
| Rendement des fonds propres | 4.8% |
| Marge nette | 32.0% |
| Dernière mise à jour des bénéfices | 31 Mar 2024 |
Mises à jour récentes des performances passées
Recent updates
Sansure Biotech (SHSE:688289) May Have Issues Allocating Its Capital
Jun 03
Why Sansure Biotech's (SHSE:688289) Soft Earnings Are Just The Beginning Of Its Problems
May 03Sansure Biotech Inc.'s (SHSE:688289) Business Is Trailing The Industry But Its Shares Aren't
Apr 26Sansure Biotech's (SHSE:688289) Returns On Capital Are Heading Higher
Feb 28Ventilation des recettes et des dépenses
Comment Sansure Biotech gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Mar 24 | 1,203 | 385 | 642 | 204 |
| 31 Dec 23 | 1,007 | 364 | 552 | 195 |
| 30 Sep 23 | 3,015 | 638 | 868 | 289 |
| 30 Jun 23 | 4,188 | 904 | 930 | 321 |
| 31 Mar 23 | 5,206 | 1,345 | 949 | 334 |
| 31 Dec 22 | 6,450 | 1,937 | 985 | 331 |
| 30 Sep 22 | 5,316 | 2,084 | 599 | 276 |
| 30 Jun 22 | 5,176 | 2,247 | 568 | 235 |
| 31 Mar 22 | 4,791 | 2,272 | 499 | 208 |
| 31 Dec 21 | 4,515 | 2,243 | 507 | 187 |
| 30 Sep 21 | 4,425 | 2,361 | 464 | 111 |
| 30 Jun 21 | 4,691 | 2,506 | 566 | 106 |
| 31 Mar 21 | 5,526 | 3,046 | 672 | 95 |
| 31 Dec 20 | 4,763 | 2,617 | 627 | 83 |
| 30 Sep 20 | 3,727 | 2,034 | 575 | 76 |
| 30 Jun 20 | 2,299 | 1,263 | 355 | 50 |
| 31 Mar 20 | 683 | 233 | 211 | 40 |
| 31 Dec 19 | 365 | 39 | 161 | 39 |
| 31 Dec 18 | 303 | 7 | 134 | 35 |
| 31 Dec 17 | 225 | -11 | 105 | 28 |
Des revenus de qualité: 688289 has a high level of non-cash earnings.
Augmentation de la marge bénéficiaire: 688289's current net profit margins (32%) are higher than last year (25.8%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 688289's earnings have declined by 9% per year over the past 5 years.
Accélération de la croissance: 688289's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: 688289 had negative earnings growth (-71.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (1.7%).
Rendement des fonds propres
ROE élevé: 688289's Return on Equity (4.8%) is considered low.